RxDoctor Payments Data

Todd Cooper

Pediatric Hematology-Oncology · Birmingham, ALNPI 1205943701

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $2,025 of the $2,326 with a category attached, or 87.1%. Janssen Research & Development, LLC accounts for 87.1% of it on its own, with 1 other manufacturer making up the rest. Reporting peaked in 2021 at $2,039 and has fallen 96.3% since, to $75 in 2025.

$2,326in general payments, 2019–2025

Across 6 payments — averaging $387.64 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Janssen Research & Development, LLC$2K
  • Jazz Pharmaceuticals Inc.$301
$3,013,718in research payments, 2019–2025

Across 55 payments — averaging $54,795 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Foundation Medicine, Inc.$2.1M
  • Jazz Pharmaceuticals Inc.$471K
  • Regeneron$243K
  • AbbVie$194K
  • Novartis$3K

What the payments were for

  • Consulting fees$2,02587%
  • Travel & lodging$1296%
  • Food & beverage$1717%

General payments by program year

19
21
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$2,326 in reported general payments places this provider in the 70th percentile of 38 pediatric hematology-oncology providers in Alabama.

See all pediatric hematology-oncology providers in Alabama

Other pediatric hematology-oncology in Birmingham

See the full list for Alabama

Where these figures come from

Is this you, or does something look wrong? →